Journal Guide

Pharmacological Research provides a rapid information exchange medium for specialists within the discipline of pharmacology. The journal publishes papers on basic and applied pharmacological research and is proud of its rapid publication of accepted papers.Invited and unsolicited review articles are also featured.Research Areas are:• Biochemical and molecular pharmacology• Cardiovascular pharmacology• Gastrointestinal pharmacology• Clinical pharmacology, if addressing novel mechanisms of action• Respiratory tract pharmacology• Urogenital tract pharmacology• Pharmacology of tissue repair• Neuropharmacology, psychopharmacology, and neuroendocrinology• Chemotherapy and cancer therapy• Immunopharmacology• Pharmacological applications of genomics• Pharmacology of aging• Nutraceuticals, if relevant to human diseaseNote that ethnopharmacological studies generally do not fall into the scope of this journal. Exceptions are made for papers addressing the mechanisms of actions or the clinical applications of worldwide-used natural substances. Clinical studies on commercially-available nutraceuticals are also taken into consideration.Immediate rejection criteria are:1. Ethnopharmacological papers, namely studies that deal with locally-consumed plants.2. In vitro antioxidant activity of plant extracts and pure compounds isolated from them.3. Papers that describe pharmacological activities of plants which are not easily found worldwide, eg, Chinese herbs.4. Papers reporting pharmacological activities of novel compounds if no proper controls with known substances are performed.5. Papers describing the pharmacological activities of natural compounds are considered only if they identify novel mechanisms of action. In particular, Pharmacol Research does not publish papers that describe• Single dose studies with very few animals, no dose-response studies.• In-vitro assays with single dose or very high dose, measuring only one endpoint.• Repetition of a simple bioassay for yet another extract or plant.

This quarterly journal showcases important review articles on topics of high current interest. Topics covered have included biochemical and cellular pharmacology, drug metabolism and disposition, renal pharmacology, neuropharmacology, behavioral pharmacology, clinical pharmacology, and toxicology. IUPHAR nomenclature reports are published here.

Pharmacology is an international journal committed to sharing the latest findings, news, and concepts pertaining to drug discovery, development, and therapy. Original scientific research presented in this journal stretches from basic to clinical studies, mirroring the scope which spans from bench-to-bedside research to modern reverse translational studies and precision medicine approaches. The journal primarily publishes research articles, reviews and commentaries to encourage knowledge transfer and discussion among the audience with an interest in experimental and clinical pharmacology, toxicology, pharmaceutical medicine, and biomedical sciences.

Pharmacology & Therapeutics presents lucid, critical and authoritative reviews of currently important topics in pharmacology. Since articles are commissioned, instructions to authors are provided by the editor responsible for recruiting the work. Celebrating its 20th year of scientific excellence, Pharmacology & Therapeutics continues to be among the top 10 most cited journals in pharmacology.Benefits to authorsWe also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services .Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our support pages: http://support.elsevier.com

Pharmacology Biochemistry & Behavior publishes original reports in the areas of pharmacology and biochemistry in which the primary emphasis and theoretical context are behavioral. Contributions may involve clinical, preclinical, or basic research. Purely behavioral studies and toxicology studies will not be published unless they have directly demonstrable relevance to the areas of pharmacology or biochemistry. Papers describing the behavioral effects of novel psychoactive drugs in models of psychiatric diseases must include a positive control.Benefits to authorsWe also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services.Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our support pages: http://support.elsevier.com

Phytomedicine is published to attract and disseminate innovative and expert findings in the fields of phytopharmacology, phytotherapy and phytotoxicology, as a reference source for researchers in these fields, and with the aim to set international standards in their methodology. The journal publishes research results on phytotherapy (clinical trials), phytopharmacology, pharmacognosy, standardization and phytotoxicology, obtained with plant extracts as well as isolated compounds from these extracts and phytopharmaceuticals. Phytomedicine is targeted towards papers of a practical nature. The papers published in this journal are also useful to drug regulatory authorities in deciding whether to approve certain phytomedicines or not. Phytomedicine consists of the following sections: Case reports, Pharmacological and molecularbiological studies, Screening studies (only when focused on plant extracts or isolated compounds with extraordinary activities, Chemical structure - activity studies, Chemical analysis and standardization of plant drugs and phytopharmaceuticals, Reviews (by invitation).

Phytotherapy Research is a monthly, international journal for the publication of original research papers, short communications, reviews and letters on medicinal plant research. Key areas of interest are pharmacology, toxicology, and the clinical applications of herbs and natural products in medicine, from case histories to full clinical trials, including studies of herb-drug interactions and other aspects of the safety of herbal medicines. Papers concerned with the effects of common food ingredients and standardised plant extracts, including commercial products, are particularly welcome, as are mechanistic studies on isolated natural products. Short communications dealing with the pharmacology and screening of crude or uncharacterised extracts will be considered for publication only if they are clearly of interest to our international readership and are not deemed more suitable for a regional audience. Phytotherapy Research does not publish agricultural, phytochemical, structure elucidation, quality control or botanical identification papers unless directly pertinent to the pharmacological effects or overall safety of plant based medicines currently in use.

La phytothérapie fait partie de votre pratique quotidienne : la revue PHYTOTHÉRAPIE est l'outil de référence dont vous avez besoin. C'est la seule revue francophone scientifique de formation médicale continue sur ce domaine. La revue PHYTOTHÉRAPIE fait le lien entre le monde de la recherche et les praticiens qui sont sur le terrain. Sous la responsabilité du Dr Paul Goetz, rédacteur en chef, assisté d'un comité de rédaction regroupant des spécialistes francophones de référence, la revue PHYTOTHÉRAPIE diffuse des articles scientifiques, provenant d?universitaires, mais également de cliniciens reconnus. Elle aborde tous les domaines de la phytothérapie - pharmacognosie, ethnobotanique, ethnopharmacologie, galénique, clinique, nutrition, aromathérapie et biothérapie, monographies médicalisées - et propose des informations sur son actualité - phytonews, législation, comptes rendus de congrès, agenda, formations, web.

Planta Medica is one of the leading international journals in the research area of natural products of any origin – from characterized multi-compound mixtures to defined natural products. Planta Medica accepts original research papers and reviews with a strong emphasis on originality and scientific quality.

Progress in Neuro-Psychopharmacology & Biological Psychiatry does not publish work on the actions of biological extracts unless the pharmacological active molecular substrate and/or specific receptor binding properties of the extract compounds are elucidated.

Benefits to authors
We also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our http://www.elsevier.com/wps/find/authorsview.authors/authorservices author services .

Please see our http://www.elsevier.com/wps/find/journaldescription.cws_home/525488/authorinstructionsGuide for Authors for information on article submission. If you require any further information or help, please visit our support pages: http://support.elsevier.com

Prostaglandins & Other Lipid Mediators is the original and foremost journal dealing with prostaglandins and related lipid mediator substances. It includes basic and clinical studies related to the pharmacology, physiology, pathology and biochemistry of lipid mediators.Please bookmark this URL: http://www.elsevier.com/locate/prostaglandinsUS National Institutes of Health (NIH) voluntary posting ("Public Access") policyProstaglandins & Other Lipid Mediators and Elsevier facilitate the author's response to the NIH Public Access Policy. For more details please see the Guide for authorsBenefits to authorsWe also provide many author benefits, such as free PDFs, a liberal copyright policy, special discounts on Elsevier publications and much more. Please click here for more information on our author services .Please see our Guide for Authors for information on article submission. If you require any further information or help, please visit our support pages: http://support.elsevier.com

Psychopharmacology is an international journal that covers the broad topic of elucidating mechanisms by which drugs affect behavior. The scope of the journal extends from clinical psychopharmacology, including trials, to experimental studies on the effects of drugs on cognition and behavior in humans and laboratory studies in experimental animals. The research methodologies covered range from neurochemical assays and electrophysiological recording to studies of functional neuroimaging, and the methods of experimental psychology and ethology, as well as clinical neurology and psychiatry.

At the heart of open access for the global chemistry community. RSC Advances publishes advances in chemistry, and in topics of interest to the chemistry community.

RSC Chemical Biology is a gold open access journal dedicated to publishing and disseminating exceptional, breakthrough research and high-quality reviews at the interface of chemistry and biology. We welcome contributions from across the breadth of the chemical biology field. This includes Sensing and Imaging, Bioorthogonal chemistry, Biosynthesis, Biomimetics and Bioengineering, Synthetic biology, Directed evolution, Drugs development and mechanism of action, Glycoscience, Natural products, Nucleic acids, Peptides, Phenotypic screening, Proteins (including protein-protein interactions, modifications, structure and function) We are particularly interested in reports on the application of chemical tools to probe, explore and visualize biological systems and processes to provide insights into molecular mechanisms in health and disease. We also encourage translational research that bridges chemistry and chemical biology to medicine.

RSC Medicinal Chemistry publishes significant research in medicinal chemistry and related drug discovery science. Research articles published in RSC Medicinal Chemistry must show a breakthrough or significant advance on previously published work, or bring new thinking or results that will have a strong impact in their field. Topics within the journal's scope include, but are not limited to: design, synthesis and biological evaluation of novel chemical entities or biotherapeutic modalities; modifications of known chemical entities or biotherapeutic modalities that result in a significantly greater understanding of their structure-activity relationships, an improvement of their properties or provide other information of significant value; novel methodologies and technologies in the broader chemical and biological sciences; computational, machine learning and artificial intelligence (AI) studies are welcome where they significantly advance medicinal chemistry knowledge; studies that examine the effect of the molecular structure of a compound on pharmacokinetic behaviour and pharmacodynamics; studies that present new insights into drug design based on analysis of existing experimental datasets or new theoretical approaches if supported by experimental evidence; studies presenting new drug delivery systems with novel chemical agents are welcomed, in particular those that involve chemical modification of the delivery system of conjugation with novel delivery vectors.

Reviews on Recent Clinical Trials publishes frontier reviews, original research articles, drug clinical trial studies and guest edited thematic issues on recent clinical trials of major importance. The journal's aim is to publish the highest quality articles in the field. Topics covered include: important Phase I – IV clinical trial studies, clinical investigations at all stages of development and therapeutics.